Cited by 396Per- and polyfluoroalkyl substances researchPeroxisome Proliferator-Activated ReceptorsEffects and risks of endocrine disrupting chemicals

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (α, β/δ, γ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate

Takacs, Margy L., Abbott, Barbara D.·2007·Toxicological Sciences

DOI 10.1093/toxsci/kfl135

Open this paper in CoChat — free account

Abstract

This study evaluates the potential for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) to activate peroxisome proliferator-activated receptors (PPARs), using a transient transfection cell assay. Cos-1 cells were cultured in Dulbecco's Minimal Essential Medium (DMEM) with fetal bovine serum in 96-well plates and transfected with mouse or human PPARalpha, beta/delta, or gamma reporter plasmids. Transfected cells were exposed to PFOA (0.5-100 microM), PFOS (1-250 microM), positive controls (i.e., known agonists and antagonists), and negative controls (i.e., DMEM, 0.1% water, and 0.1% dimethyl sulfoxide). Following treatment for 24 h, activity was measured using the Luciferase reporter assay. In this assay, PFOA had more transactivity than PFOS with both the mouse and human PPAR isoforms. PFOA significantly increased mouse and human PPARalpha and mouse PPARbeta/delta activity relative to vehicle. PFOS significantly increased activation of mouse PPARalpha and PPARbeta/delta isoforms. No significant activation of mouse or human PPARgamma was observed with PFOA or PFOS. The PPARalpha antagonist, MK-886, significantly suppressed PFOA and PFOS activity of mouse and human PPARalpha. The PPARgamma antagonist, GW9662, significantly suppressed PFOA activity on the human isoform. In conclusion, this study characterized the dose response and differential activation of mouse and human PPARalpha, beta/delta, gamma by PFOA and PFOS. While this model allows opportunities to compare potential activation by perfluoroalkyl acids, it only evaluates the interaction and activation of the PPAR reporter constructs and is not necessarily predictive of a toxicological response in vivo.

Integrity signals

Registry

Crossref · 10.1093/toxsci/kfl135

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
Global Distribution of Perfluorooctane Sulfonate in Wildlife
Giesy, J. P., & Kannan, K. (2001) · Environmental Science & Technology · doi:10.1021/es001834k · Cited by 2,750
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Peer Reviewed: Perfluorochemical Surfactants in the Environment
Giesy, J. P., & Kannan, K. (2002) · Environmental Science & Technology · doi:10.1021/es022253t · Cited by 1,103
Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices
Hansen, K. J., Clemen, L. A., Ellefson, M. E., & Johnson, H. O. (2001) · Environmental Science & Technology · doi:10.1021/es001489z · Cited by 923
The Developmental Toxicity of Perfluoroalkyl Acids and Their Derivatives
Lau, C., Butenhoff, J. L., & Rogers, J. M. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.11.031 · Cited by 867
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
The toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM Patients
Auboeuf, D., Rieusset, J., Lluis Fajas, A., Vallier, P., Fréring, V., Riou, J. P., Staels, B., Auwerx, J. H., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 699

Show all 53 references

Research works printed but not linked: 3

2005, Evaluation of the half-life (T1/2) of elimination of perfluorooctanoate (PFOA) from human serum, Toxicologist, 84, 253
1997, Principles of Medical Biology, Molecular and Cellular Endocrinology
U.S. Environmental Protection Agency, 2005, Draft Risk Assessment of Human Health Effects Associated with Exposure to Perfluorooctanoic Acid and its Salts, January, 2005

Sorted by citations

Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Endocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts Scientific Opinion of the Panel on Contaminants in the Food chain
(EFSA), E. F. S. A. (2008) · EFSA Journal · doi:10.2903/j.efsa.2008.653 · Cited by 549
Toxicology of perfluorinated compounds
Stahl, T., Mattern, D., & Brunn, H. (2011) · Environmental Sciences Europe · doi:10.1186/2190-4715-23-38 · Cited by 432
Perfluoroalkyl substances (PFAS) and their effects on the placenta, pregnancy, and child development: a potential mechanistic role for placental peroxisome proliferator-activated receptors (PPARs)
Szilagyi, J. T., Avula, V., & Fry, R. C. (2020) · Current Environmental Health Reports · doi:10.1007/s40572-020-00279-0 · Cited by 328
Opinion of the Scientific Panel on Contaminants in the Food chain on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts
Benford, D., de Boer, J., Carere, A., Domenico, A. D., Johansson, N., Schrenk, D., Schoeters, G. E. R., de Voogt, P., & Dellatte, E. (2008) · UvA-DARE (University of Amsterdam) · Cited by 320
Consideration of pathways for immunotoxicity of per-and polyfluoroalkyl substances (PFAS)
Ehrlich, V., Bil, W., Vandebriel, R., Granum, B., Luijten, M., Lindeman, B., Grandjean, P., Kaiser, A.-M., Hauzenberger, I., Hartmann, C., et al. (2023) · Environmental Health · doi:10.1186/s12940-022-00958-5 · Cited by 318
Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury
Roth, K., Yang, Z., Agarwal, M., Liu, W. J., Peng, Z., Long, Z., Birbeck, J. A., Westrick, J. A., Liu, W., & Petriello, M. C. (2021) · Environment International · doi:10.1016/j.envint.2021.106843 · Cited by 322
Peroxisome Proliferator-Activated Receptor γ Is a Target for Halogenated Analogs of Bisphenol A
Riu, A., Grimaldi, M., le Maire, A., Bey, G., Phillips, K. J., Boulahtouf, A., Perdu-Durand, E., Zalko, D., Bourguet, W., & Balaguer, P. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1003328 · Cited by 315
Activation of Mouse and Human Peroxisome Proliferator−Activated Receptor Alpha by Perfluoroalkyl Acids of Different Functional Groups and Chain Lengths
Wolf, C. J., Takacs, M. L., Schmid, J. E., Lau, C. S., & Abbott, B. D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn166 · Cited by 302
Self-citation
Phenotypic Dichotomy Following Developmental Exposure to Perfluorooctanoic Acid (PFOA) in Female CD-1 Mice: Low Doses Induce Elevated Serum Leptin and Insulin, and Overweight in Mid-life☆☆
Hines, E. P., White, S. S., Stanko, J. P., Gibbs-Flournoy, E. A., Lau, C., & Fenton, S. E. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.021 · Cited by 282
Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity
Janesick, A., & Blumberg, B. (2011) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20197 · Cited by 276
Molecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks
Li, K., Gao, P., Xiang, P., Zhang, X., Cui, X., & Ma, L. Q. (2016) · Environment International · doi:10.1016/j.envint.2016.11.014 · Cited by 268
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
Bjork, J. A., Butenhoff, J. L., & Wallace, K. B. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.012 · Cited by 266
Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPAR α ) as a case study
Corton, J. C., Cunningham, M. L., Hummer, B. T., Lau, C. S., Meek, B., Peters, J. M., Popp, J. A., Rhomberg, L. R., Seed, J. G., & Klaunig, J. E. (2013) · Critical Reviews in Toxicology · doi:10.3109/10408444.2013.835784 · Cited by 246
Activation of Human Nuclear Receptors by Perfluoroalkylated Substances (PFAS)
Behr, A.-C., Plinsch, C., Braeuning, A., & Buhrke, T. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104700 · Cited by 235
Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in a Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley
Steenland, K., Zhao, L., Winquist, A. G., & Parks, C. G. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1206449 · Cited by 242
Impact of Environmental Chemicals on Key Transcription Regulators and Correlation to Toxicity End Points within EPA’s ToxCast Program
Martin, M. T., Dix, D. J., Judson, R., Kavlock, R. J., Reif, D. M., Richard, A. M., Rotroff, D. M., Romanov, S., Medvedev, A. V., Poltoratskaya, N., et al. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900325g · Cited by 217
PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport
Wan, H. T., Zhao, Y. G., Wei, X., Hui, K. Y., Giesy, J. P., & Wong, C. K. C. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.010 · Cited by 226
PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
Rosen, M. B., Das, K. P., Rooney, J. P., Abbott, B. D., Lau, C. S., & Corton, J. C. (2017) · Toxicology · doi:10.1016/j.tox.2017.05.013 · Cited by 217
Self-citation
Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS)
Chang, S., Thibodeaux, J. R., Eastvold, M. L., Ehresman, D. J., Bjork, J. A., Froehlich, J. W., Lau, C. S., Singh, R. J., Wallace, K. B., & Butenhoff, J. L. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.014 · Cited by 209
In Vitro Activity of a Panel of Per- and Polyfluoroalkyl Substances (PFAS), Fatty Acids, and Pharmaceuticals in Peroxisome Proliferator-Activated Receptor (PPAR) Alpha, PPAR Gamma, and Estrogen Receptor Assays
Evans, N., Conley, J. M., Cardon, M., Hartig, P., Medlock-Kakaley, E., & Gray, L. E. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116136 · Cited by 208
Perfluorinated compounds: Emerging POPs with potential immunotoxicity
Corsini, E., Luebke, R. W., Germolec, D. R., & DeWitt, J. C. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.038 · Cited by 213
Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPARα and CAR
Rosen, M. B., Lee, J. S., Ren, H., Vallanat, B., Liu, J., Waalkes, M. P., Abbott, B. D., Lau, C. S., & Corton, J. C. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn025 · Cited by 200
Self-citation
Serum Polyfluoroalkyl Concentrations, Asthma Outcomes, and Immunological Markers in a Case–Control Study of Taiwanese Children
Dong, G., Tung, K., Tsai, C., Liu, M.-M., Wang, D., Liu, W., Jin, Y., Hsieh, W., Lee, Y. L., & Chen, P. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1205351 · Cited by 199
Induction of time-dependent oxidative stress and related transcriptional effects of perfluorododecanoic acid in zebrafish liver
Liu, Y., Wang, J., WEI, Y., Zhang, H., XU, M., & DAI, J. (2008) · Aquatic Toxicology · doi:10.1016/j.aquatox.2008.07.009 · Cited by 192
Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism
Yu, W., Liu, W., & Jin, Y. (2008) · Environmental Toxicology and Chemistry · doi:10.1897/08-345.1 · Cited by 195
Minireview: The Case for Obesogens
Grün, F., & Blumberg, B. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0485 · Cited by 188
Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
Fragki, S., Dirven, H. A. A. M., Fletcher, T., Grasl‐Kraupp, B., Gützkow, K. B., Hoogenboom, L. A. P., Kersten, S., Lindeman, B., Louisse, J., Peijnenburg, A., et al. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1888073 · Cited by 196
Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: Evidence of racial/ethnic and geographic differences in PFAS exposure
Park, S. K., Peng, Q., Ding, N., Mukherjee, B., & Harlow, S. D. (2019) · Environmental Research · doi:10.1016/j.envres.2019.05.028 · Cited by 188
The PPARα-Dependent Rodent Liver Tumor Response Is Not Relevant to Humans: Addressing Misconceptions
Corton, J. C., Peters, J. M., & Klaunig, J. E. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2094-7 · Cited by 175
Serum polyfluoroalkyl chemicals are associated with risk of cardiovascular diseases in national US population
Huang, M., Jiao, J., Zhuang, P., Chen, X., Wang, J., & Zhang, Y. (2018) · Environment International · doi:10.1016/j.envint.2018.05.051 · Cited by 178
In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs)
Corsini, E., Sangiovanni, E., Avogadro, A., Galbiati, V., Viviani, B., Marinovich, M., Galli, C. L., Dell’Agli, M., & Germolec, D. R. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.11.004 · Cited by 173
Endocrine disrupting chemicals: Impacts on human fertility and fecundity during the peri-conception period
Green, M. P., Harvey, A. J., Finger, B. J., & Tarulli, G. A. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110694 · Cited by 168
A Critical Review and Meta-Analysis of Impacts of Per- and Polyfluorinated Substances on the Brain and Behavior
Starnes, H. M., Rock, K. D., Jackson, T. W., & Belcher, S. M. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.881584 · Cited by 166
“For example, PFOA has been shown to interact with PPARα, γ, and β/δ and induce adipogenesis in 3T3-L1 cells, cells with a fibroblast morphology that can differentiate into a cell with an adipocyte-like phenotype (Takacs and Abbott, 2007; Watkins et al., 2013; Li et al., 2019).”
Background
Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): Further investigation of C4–C12 compounds
Wolf, C. J., Schmid, J. E., Lau, C. S., & Abbott, B. D. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.09.009 · Cited by 160
Self-citation
PFOS induced lipid metabolism disturbances in BALB/c mice through inhibition of low density lipoproteins excretion
Wang, L., Wang, Y., Liang, Y., Li, J., Liu, Y., Zhang, J., Zhang, A., Fu, J., & Jiang, G. (2014) · Scientific Reports · doi:10.1038/srep04582 · Cited by 159
Subchronic Hepatotoxicity Effects of 6:2 Chlorinated Polyfluorinated Ether Sulfonate (6:2 Cl-PFESA), a Novel Perfluorooctanesulfonate (PFOS) Alternative, on Adult Male Mice
Zhang, H., Zhou, X., Sheng, N., Cui, R., Cui, Q., Guo, H., Guo, Y., Sun, Y., & Dai, J. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.8b04368 · Cited by 157
Per- and polyfluoroalkyl substances (PFAS) exposure and thyroid cancer risk
van Gerwen, M. A. G., Colicino, E., Guan, H., Dolios, G., Nadkarni, G. N., Vermeulen, R. C. H., Wolff, M. S., Arora, M., Genden, E. M., & Petrick, L. M. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104831 · Cited by 158
Ammonium Perfluorooctanoate Production and Occupational Mortality
Lundin, J. I., Alexander, B. H., Olsen, G. W., & Church, T. R. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181b5f395 · Cited by 156
Influence of exposure to perfluoroalkyl substances (PFASs) on the Korean general population: 10-year trend and health effects
Seo, S.-H., Son, M.-H., Choi, S., Lee, D., & Chang, Y. (2018) · Environment International · doi:10.1016/j.envint.2018.01.025 · Cited by 159
In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs)
Corsini, E., Avogadro, A., Galbiati, V., Dell’Agli, M., Marinovich, M., Galli, C. L., & Germolec, D. R. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.11.004 · Cited by 153
Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure
Houck, K. A., Patlewicz, G. Y., Richard, A. M., Williams, A. J., Shobair, M., Smeltz, M. G., Clifton, M. S., Wetmore, B. A., Medvedev, A. V., & Makarov, S. S. (2021) · Toxicology · doi:10.1016/j.tox.2021.152789 · Cited by 149
Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats
Butenhoff, J. L., Chang, S., Olsen, G. W., & Thomford, P. J. (2012) · Toxicology · doi:10.1016/j.tox.2012.01.003 · Cited by 149
Chlorinated Polyfluorinated Ether Sulfonates Exhibit Higher Activity toward Peroxisome Proliferator-Activated Receptors Signaling Pathways than Perfluorooctanesulfonate
Li, C.-H., Ren, X., Ruan, T., Cao, L.-Y., Yan, X., Guo, L., & Jiang, G. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b06327 · Cited by 146
Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study
Yu, G., Jin, M., Huang, Y., Aimuzi, R., Zheng, T., Nian, M., Tian, Y., Wang, W., Luo, Z., Shen, L., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106621 · Cited by 141
Evaluation of potential reproductive and developmental toxicity of potassium perfluorohexanesulfonate in Sprague Dawley rats
Butenhoff, J. L., Chang, S., Ehresman, D. J., & York, R. G. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.01.004 · Cited by 141
Highly fluorinated amphiphilic molecules and self-assemblies with biomedical potential
Riess, J. G. (2009) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2009.05.008 · Cited by 143
Structure-Activity Relationships and Human Relevance for Perfluoroalkyl Acid-Induced Transcriptional Activation of Peroxisome Proliferation in Liver Cell Cultures
Bjork, J. A., & Wallace, K. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp093 · Cited by 137
Gene Expression Profiling in Wild-Type and PPAR-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPAR-Independent Effects
Rosen, M. B., Schmid, J., Corton, J. C., ZEHR, R. D. J., Das, K. P., Abbott, B. D., & Lau, C. S. (2010) · PPAR Research · doi:10.1155/2010/794739 · Cited by 135
Self-citation
Gene Profiling in the Livers of Wild-type and PPARα-Null Mice Exposed to Perfluorooctanoic Acid
Rosen, M. B., Abbott, B. D., Wolf, D. C., Corton, J. C., Wood, C. R., Schmid, J. E., Das, K. P., ZEHR, R. D. J., Blair, E. T., & Lau, C. S. (2008) · Toxicologic Pathology · doi:10.1177/0192623308318208 · Cited by 137
Self-citation
Hepatocellular hypertrophy and cell proliferation in Sprague–Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR
Elcombe, C. R., Elcombe, B. M., Foster, J. R., Chang, S., Ehresman, D. J., & Butenhoff, J. L. (2012) · Toxicology · doi:10.1016/j.tox.2011.12.014 · Cited by 131
Comparative toxicometabolomics of perfluorooctanoic acid (PFOA) and next-generation perfluoroalkyl substances
Gebreab, K. Y., Eeza, M. N. H., Bai, T., Zuberi, Z., Matysik, J., Ο'Shea, K. Ε., Alia, A., & Berry, J. P. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114928 · Cited by 131
Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells
Behr, A., Kwiatkowski, A., Ståhlman, M., Schmidt, F. F., Luckert, C., Braeuning, A., & Buhrke, T. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02732-3 · Cited by 125
Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPARα) in the mouse
Abbott, B. D., Wolf, C. J., Das, K. P., ZEHR, R. D. J., Schmid, J. E., Lindstrom, A. B., Strynar, M. J., & Lau, C. S. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.05.061 · Cited by 124
Self-citation
Binding of PFOS to Serum Albumin and DNA: Insight into the Molecular Toxicity of Perfluorochemicals
Zhang, X., Chen, L., Fei, X.-C., Ma, Y.-S., & Gao, H.-W. (2009) · BMC Molecular Biology · doi:10.1186/1471-2199-10-16 · Cited by 119
Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet
Schlezinger, J. J., Puckett, H. M., Oliver, J., Nielsen, G. H., Heiger‐Bernays, W., & Webster, T. F. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115204 · Cited by 122
Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid
Fitz-Simon, N., Fletcher, T., Luster, M. I., Steenland, K., Calafat, A. M., Kato, K., & Armstrong, B. (2013) · Epidemiology · doi:10.1097/ede.0b013e31829443ee · Cited by 117
PFAS Exposures and the Human Metabolome: A Systematic Review of Epidemiological Studies
India-Aldana, S., Yao, M., Midya, V., Colicino, E., Chatzi, L., Chu, J., Gennings, C., Jones, D. P., Loos, R. J. F., Setiawan, V. W., et al. (2023) · Current Pollution Reports · doi:10.1007/s40726-023-00269-4 · Cited by 114
Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor γ
Zhang, L., Ren, X., Wan, B., & Guo, L. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.06.020 · Cited by 120
Diet as an Exposure Source and Mediator of Per- and Polyfluoroalkyl Substance (PFAS) Toxicity
Roth, K., Imran, Z., Liu, W., & Petriello, M. C. (2020) · Frontiers in Toxicology · doi:10.3389/ftox.2020.601149 · Cited by 120
Altered Fatty Acid Homeostasis and Related Toxicologic Sequelae in Rats Exposed to Dietary Potassium Perfluorooctanesulfonate (PFOS)
Curran, I. H., Hierlihy, S. L., Liston, V., Pantazopoulos, P., Nunnikhoven, A., Tittlemier, S. A., Barker, M., Trick, K. D., & Bondy, G. S. (2008) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390802361763 · Cited by 110
Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice
Yan, S., Zhang, H., Zheng, F., Sheng, N., Guo, X., & Dai, J. (2015) · Scientific Reports · doi:10.1038/srep11029 · Cited by 110
Adipogenic Activity of Oligomeric Hexafluoropropylene Oxide (Perfluorooctanoic Acid Alternative) through Peroxisome Proliferator-Activated Receptor γ Pathway
Li, C.-H., Ren, X., & Guo, L. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.8b06978 · Cited by 110
Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses
Rosen, M. B., Thibodeaux, J. R., Wood, C. R., ZEHR, R. D. J., Schmid, J. E., & Lau, C. S. (2007) · Toxicology · doi:10.1016/j.tox.2007.06.095 · Cited by 108
The Association of Prenatal Exposure to Perfluorinated Chemicals with Maternal Essential and Long-Chain Polyunsaturated Fatty Acids during Pregnancy and the Birth Weight of Their Offspring: The Hokkaido Study
Kishi, R., Nakajima, T., Goudarzi, H., Kobayashi, S., Sasaki, S., Okada, E., Miyashita, C., Itoh, S., Araki, A., Ikeno, T., et al. (2015) · Environmental Health Perspectives · doi:10.1289/ehp.1408834 · Cited by 104
Perinatal Exposure to Perfluorooctane Sulfonate Affects Glucose Metabolism in Adult Offspring
Wan, H. T., Zhao, Y. G., Leung, P. Y., & Wong, C. K. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087137 · Cited by 107
PFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathway
Xu, J., Shimpi, P. C., Armstrong, L. E., Salter, D. M., & Slitt, A. L. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.11.002 · Cited by 106
The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study
Goudarzi, H., Araki, A., Itoh, S., Sasaki, S., Miyashita, C., Mitsui, T., Nakazawa, H., Nonomura, K., & Kishi, R. (2016) · Environmental Health Perspectives · doi:10.1289/ehp142 · Cited by 97
Perfluorinated Compounds
Lau, C. S. (2012) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8340-4_3 · Cited by 106
Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice
Attema, B. J., Janssen, A. W. F., Rijkers, D., van Schothorst, E. M., Hooiveld, G. J. E. J., & Kersten, S. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101602 · Cited by 109
Structure–activity relations in binding of perfluoroalkyl compounds to human thyroid hormone T3 receptor
Ren, X., Zhang, Y., Guo, L., Qin, Z., Lv, Q., & Zhang, L. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1258-y · Cited by 104
Association between levels of serum perfluorooctane sulfate and carotid artery intima–media thickness in adolescents and young adults
Lin, C., Lin, L., Wen, T.-W., Lien, G., Chien, K., Hsu, S. H.-J., Liao, C., Sung, F.-C., Chen, P., & Su, T. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.042 · Cited by 101
A review on perfluoroalkyl acids studies: Environmental behaviors, toxic effects, and ecological and health risks
Liu, W., Wu, J., He, W., & Xu, F. (2019) · Ecosystem Health and Sustainability · doi:10.1080/20964129.2018.1558031 · Cited by 106
Lipid peroxidation and oxidative stress responses of salmon fed a diet containing perfluorooctane sulfonic- or perfluorooctane carboxylic acids
Arukwe, A., & Mortensen, A. S. (2011) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2011.06.012 · Cited by 102
Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation
Koskela, A., Finnilä, M., Korkalainen, M., Spulber, S. D., Koponen, J. M., Håkansson, H., Tuukkanen, J., & Viluksela, M. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.04.002 · Cited by 101
Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance
Klaunig, J. E., Hocevar, B. A., & Kamendulis, L. M. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.10.014 · Cited by 101
Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species
Ren, H., Vallanat, B., Nelson, D. M., Yeung, L. W. Y., Guruge, K. S., Lam, P. K. S., Lehman‐McKeeman, L. D., & Corton, J. C. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.12.011 · Cited by 99
Hepatocellular Hypertrophy and Cell Proliferation in Sprague-Dawley Rats Following Dietary Exposure to Ammonium Perfluorooctanoate Occurs through Increased Activation of the Xenosensor Nuclear Receptors PPARα and CAR/PXR
Elcombe, C. R., Elcombe, B. M., Foster, J. R., Farrar, D. G., Jung, R., Chang, S.-C., Kennedy, G. L., & Butenhoff, J. L. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0572-2 · Cited by 96
The association between prenatal exposure to perfluoroalkyl substances and childhood neurodevelopment
Spratlen, M. J., Perera, F. P., Lederman, S. A., Rauh, V., Robinson, M., Kannan, K., Trasande, L., & Herbstman, J. B. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114444 · Cited by 98
PFOS elicits transcriptional responses of the ER, AHR and PPAR pathways in Oryzias melastigma in a stage-specific manner
Fang, C., Wu, X., Huang, Q., Liao, Y., Liu, L., Qiu, L., Shen, H., & Dong, S. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.10.009 · Cited by 94
Perfluorooctanoic Acid (PFOA)–induced Liver Lesions in Two Strains of Mice Following Developmental Exposures
Filgo, A. J., Quist, E. M., Hoenerhoff, M. J., Brix, A. E., Kissling, G. E., & Fenton, S. E. (2014) · Toxicologic Pathology · doi:10.1177/0192623314558463 · Cited by 93
Nontarget Screening of Per- and Polyfluoroalkyl Substances Binding to Human Liver Fatty Acid Binding Protein
Yang, D., Han, J., Hall, D. R., Sun, J., Fu, J., Kutarna, S., Houck, K. A., LaLone, C. A., Doering, J. A., Ng, C. A., et al. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c00049 · Cited by 94
Perfluorooctane sulfonate-induced changes in fetal rat liver gene expression.
Bjork, J., Lau, C., Chang, S., Butenhoff, J., & Wallace, K. (2008) · Toxicology · doi:10.1016/j.tox.2008.06.007 · Cited by 85
Association of perfluoroalkyl substances exposure with impaired lung function in children
Qin, X.-D., Qian, Z. (., Dharmage, S. C., Perret, J., Geiger, S. D., Rigdon, S. E., Howard, S., Zeng, X.-W., Hu, L.-W., Yang, B.-Y., et al. (2017) · Environmental Research · doi:10.1016/j.envres.2017.01.025 · Cited by 90
PFAS and Potential Adverse Effects on Bone and Adipose Tissue through Interactions with PPARγ
Kirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021) · Endocrinology · doi:10.1210/endocr/bqab194 · Cited by 90
PFOA and PFOS promote diabetic renal injury in vitro by impairing the metabolisms of amino acids and purines
Gong, X., Yang, C., Hong, Y., Chung, A. C. K., & Cai, Z. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.04.208 · Cited by 89
Exposure to GenX and Its Novel Analogs Disrupts Hepatic Bile Acid Metabolism in Male Mice
Guo, H., Chen, J., Zhang, H., Yao, J., Sheng, N., Li, Q., Guo, Y., Wu, C., Xie, W., & Dai, J. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c02471 · Cited by 89
Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice
Qazi, M. R., Abedi, M. R., Nelson, B. D., DePierre, J. W., & Abedi‐Valugerdi, M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.009 · Cited by 91
Perfluorooctane sulfonate triggers tight junction “opening” in brain endothelial cells via phosphatidylinositol 3-kinase
Wang, X., Li, B., Zhao, W., Liu, Y., Shang, D., Fang, W., & Chen, Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.128 · Cited by 94
Perfluoroalkyl substances and risk of type II diabetes: A prospective nested case-control study
Donat-Vargas, C., Bergdahl, I. A., Tornevi, A., Wennberg, M., Sommar, J., Kiviranta, H., Koponen, J., Rolandsson, O., & Åkesson, A. (2019) · Environment International · doi:10.1016/j.envint.2018.12.026 · Cited by 88
Screening of Potential PFOS Alternatives To Decrease Liver Bioaccumulation: Experimental and Computational Approaches
Cao, H., Zhou, Z., Wang, L., Liu, G., Sun, Y., Wang, Y., Wang, T., & Liang, Y. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.8b05564 · Cited by 92
Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes
Buhrke, T., Krüger, E., Pevny, S., Rößler, M., Bitter, K., & Lampen, A. (2015) · Toxicology · doi:10.1016/j.tox.2015.04.004 · Cited by 86
Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARαand T- and B-cell targeting
DeWitt, J. C., Williams, W. C., Creech, N. J., & Luebke, R. W. (2015) · Journal of Immunotoxicology · doi:10.3109/1547691x.2014.996682 · Cited by 84
Effects of prenatal perfluoroalkyl acid exposure on cord blood IGF2/H19 methylation and ponderal index: The Hokkaido Study
Kobayashi, S., Azumi, K., Goudarzi, H., Araki, A., Miyashita, C., Kobayashi, S., Itoh, S., Sasaki, S., Ishizuka, M., Nakazawa, H., et al. (2016) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2016.50 · Cited by 83
Comparative in vitro toxicity assessment of perfluorinated carboxylic acids
Mahapatra, C. T., Damayanti, N. P., Guffey, S. C., Serafin, J., Irudayaraj, J., & Sepúlveda, M. S. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3418 · Cited by 89
Prenatal Exposure to Per- and Polyfluoroalkyl Substances, Umbilical Cord Blood DNA Methylation, and Cardio-Metabolic Indicators in Newborns: The Healthy Start Study
Starling, A. P., Liu, C., Shen, G., Yang, I. V., Kechris, K. J., Borengasser, S. J., Boyle, K. E., Zhang, W., Smith, H., Calafat, A. M., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp6888 · Cited by 83
Nuclear Receptor Profiling of Bisphenol-A and Its Halogenated Analogues
Delfosse, V., Grimaldi, M., le Maire, A., Bourguet, W., & Balaguer, P. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800095-3.00009-2 · Cited by 83
Transcriptional effects of PFOS in isolated hepatocytes from Atlantic salmon Salmo salar L.
Krøvel, A. V., Søfteland, L., Torstensen, B. E., & Olsvik, P. A. (2008) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2008.03.001 · Cited by 80

Authors: Takacs, M. L., & Abbott, B. D.
Affiliations: Environmental Protection Agency (US)
ORCID: Abbott, Barbara D.
Venue: Toxicological Sciences
Publisher: Oxford University Press (OUP)
Published: 2006-10-17
Volume: 95
Issue: 1
Pages: 108-117
ISSN: 1096-0929 (ISSN-L)
1096-6080
DOI: 10.1093/toxsci/kfl135
OpenAlex: W2120447865
Cited by: 396
References: 53
Citations by year: 2026: 23 · 2025: 29 · 2024: 26 · 2023: 24 · 2022: 24 · 2021: 33 · 2020: 25 · 2019: 15 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 17 · 2014: 20 · 2013: 16 · 2012: 17
FWCI: 13.57
Type: journal article
Language: en
Open access: closed
Locations: Toxicological Sciences (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords: perfluorooctanoic acid, PFOS, perfluoroalkyl acids, peroxisome proliferator-activated receptors, PPARα, PPARδ, PPARγ, receptor activation, MK-886, GW9662, dose-response relationship, perfluorinated compounds
MeSH terms: Animals, Caprylates, Chlorocebus aethiops, Dose-Response Relationship, Drug, Environmental Pollutants, Fluorocarbons, Humans, Luciferases, Species Specificity, Transfection, Transcriptional Activation, Alkanesulfonic Acids, Genes, Reporter, COS Cells, Peroxisome Proliferator-Activated Receptors, PPAR alpha, PPAR delta, PPAR gamma, PPAR-beta, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (α, β/δ, γ) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks